436 related articles for article (PubMed ID: 33646447)
41.
Takahashi T; Saito A; Kuronuma K; Nishikiori H; Chiba H
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143828
[TBL] [Abstract][Full Text] [Related]
42. Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide.
Nettleton E; Sattui SE; Wallace Z; Putman M
Arthritis Care Res (Hoboken); 2024 Feb; 76(2):288-294. PubMed ID: 37643919
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
Lin CY; Ko CH; Hsu CY; Chen HA
Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
[TBL] [Abstract][Full Text] [Related]
44. Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?
Schoffelen AF; van Lelyveld SF; Barth RE; Gras L; de Wolf F; Netea MG; Hoepelman AI;
AIDS; 2013 Apr; 27(7):1179-84. PubMed ID: 23276810
[TBL] [Abstract][Full Text] [Related]
45. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
46. Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy.
Bonilla-Abadía F; Betancurt JF; Pineda JC; Vélez JD; Tobón GJ; Cañas CA
Clin Rheumatol; 2014 Mar; 33(3):415-8. PubMed ID: 24402739
[TBL] [Abstract][Full Text] [Related]
47. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
[TBL] [Abstract][Full Text] [Related]
48. Healthcare-associated Pneumocystis jirovecii Pneumonia (PJP) Infection in HIV-negative Adults: a Multicenter Study.
Zalmanovich A; Ben-Ami R; Rahav G; Alon D; Moses A; Olshtain-Pops K; Weinberger M; Shitrit P; Katzir M; Gottesman BS; Chowers M
Isr Med Assoc J; 2021 May; 23(5):312-317. PubMed ID: 34024049
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study.
Chen HH; Lin CH; Hsieh TY; Chen DY; Ying JC; Chao WC
Rheumatology (Oxford); 2021 Nov; 60(11):5351-5361. PubMed ID: 33547781
[TBL] [Abstract][Full Text] [Related]
50. [Host factors and characteristics of hospitalized patients with pneumocystis jirovecii pneumonia].
Chen RX; Sun YX; Liu XN; Shao C; Huang H; Hu K; Xu J; Li J; Yi X; Zhang ZJ; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Sep; 45(9):881-887. PubMed ID: 36097925
[No Abstract] [Full Text] [Related]
51. Pneumocystis jirovecii pneumonia in systemic lupus erythematosus from southern Taiwan.
Weng CT; Liu MF; Weng MY; Lee NY; Wang MC; Lin WC; Ou CY; Lai WW; Hsu SC; Chao SC; Chung TJ; Lee CT; Shieh CC; Wang JY; Wang CR
J Clin Rheumatol; 2013 Aug; 19(5):252-8. PubMed ID: 23872548
[TBL] [Abstract][Full Text] [Related]
52. Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.
Kolstad KD; Mayo JA; Chung L; Chaichian Y; Kelly VM; Druzin M; Stevenson DK; Shaw GM; Simard JF
BJOG; 2020 Jan; 127(1):70-78. PubMed ID: 31571337
[TBL] [Abstract][Full Text] [Related]
53. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
[TBL] [Abstract][Full Text] [Related]
54. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.
Cotter TG; Gathaiya N; Catania J; Loftus EV; Tremaine WJ; Baddour LM; Harmsen WS; Zinsmeister AR; Sandborn WJ; Limper AH; Pardi DS
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):850-856. PubMed ID: 28013116
[TBL] [Abstract][Full Text] [Related]
55. [Cyclophosphamide pulse therapy for refractory rheumatic diseases].
Tateishi M; Taniguchi A; Moriguchi M; Hara M; Kashiwazaki S
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Jun; 20(3):152-8. PubMed ID: 9256607
[TBL] [Abstract][Full Text] [Related]
56. Incidence and Risk Factors of Mental Illnesses Among Patients with Systemic Autoimmune Rheumatic Diseases: An 18-year population-based study.
Chu WM; Chao WC; Chen DY; Ho WL; Chen HH
Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38579187
[TBL] [Abstract][Full Text] [Related]
57. Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study.
Chang CC; Lin TM; Chang YS; Chen WS; Sheu JJ; Chen YH; Chen JH
Rheumatology (Oxford); 2019 Jan; 58(1):135-143. PubMed ID: 30189048
[TBL] [Abstract][Full Text] [Related]
58. Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.
Nunokawa T; Yokogawa N; Shimada K; Sugii S
Mod Rheumatol; 2019 May; 29(3):436-440. PubMed ID: 29652202
[TBL] [Abstract][Full Text] [Related]
59. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.
Lee EH; Kim EY; Lee SH; Roh YH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2019 Feb; 9(1):2094. PubMed ID: 30765832
[TBL] [Abstract][Full Text] [Related]
60. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?
Chong WH; Saha BK; Chopra A
Infection; 2021 Dec; 49(6):1079-1090. PubMed ID: 34059997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
